Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Gut|January 13, 2001
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseA Cortot, J F Colombel, P Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?N J Talley, N Vakil, K Lauritsen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2016
Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic PeopleTumpa Dutta, Yogish C Kudva, Xuan-Mai T Persson, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled studyS V van Zanten, N Flook, N J Talley, et al.
Gastroenterology|June 1, 1996
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitisR Löfberg, A Danielsson, O Suhr, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Scandinavian Journal of Gastroenterology|July 20, 2002
Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitisS Lindgren, R Löfberg, L Bergholm, et al.
Gastroenterology|January 29, 1999
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study GroupG Hellers, A Cortot, D Jewell, et al.
Pageof 13